Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Opt-IVF for Personalized Medicine for Normal Responders

NCT: NCT07856082 · RECRUITING

NCT IDNCT07856082
StatusRECRUITING
Start Date2026-10-15
Completion2027-04-30
SponsorUrmila DIwekar (INDUSTRY)
First posted
Last updated

Brief Summary

A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.

Frequently Asked Questions

What is Opt-IVF for Personalized Medicine for Normal Responders?

Opt-IVF for Personalized Medicine for Normal Responders is a clinical trial registered under NCT07856082. Current status: RECRUITING.

What is the status of NCT07856082?

The current status of NCT07856082 (Opt-IVF for Personalized Medicine for Normal Responders) is: RECRUITING.

When did Opt-IVF for Personalized Medicine for Normal Responders start?

Opt-IVF for Personalized Medicine for Normal Responders started on 2026-10-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑